Delivering better options for life

Deaths in the United States from cervical cancer have dropped nearly 75 percent since the Pap smear was introduced about 50 years ago. What the Pap smear has done for cervical cancers, laboratory- and clinic-based researchers hope to do for other gynecologic cancers.

Better detection is only part of the story for women’s reproductive cancers. Treatment options have increased with advances in chemotherapy, the use of minimally invasive surgery and improved techniques in imaging and radiation.

Many of the treatment advances enjoyed today rose through clinical trials during the last decade. The MCG Cancer Center plays a role in bringing state-of-the-art drug interventions to patients in the surrounding community.

At MCG, gynecologic cancer patients receive on-going evaluation by a Multidisciplinary Team. Gynecologic oncologists – representing hormone therapy, chemotherapy and surgery – work together with radiation oncologists and other medical professionals to provide individualized oversight from pre-treatment through treatment and post-treatment. Representatives from the center are also part of this and other Multidisciplinary Teams, keeping them informed about the availability of trials to benefit today’s patients and future patients through research.

Learn more about the team.

[Back to Top]